Connecticut Children’s Names Chief Medical Officer

A longtime Connecticut Children’s physician is taking on a new role overseeing the health system’s clinical quality, patient safety, and hospital medical operations.
Connecticut Children’s named pediatric oncologist and physician executive Dr. Michael Isakoff, its chief medical officer, effective Jan. 4.
As chief medical officer, Isakoff will provide physician executive leadership for clinical quality and patient safety, medical staff performance, and hospital medical operations.
Isakoff has held several leadership positions within the health system, including interim physician-in-chief, president of the medical staff, and head of the division of hematology and oncology.
As leader of the division of hematology and oncology, he helped expand its clinical programs, physician faculty, research, and educational opportunities.
Growing Clinical Programs
“Mike brings the experience, credibility and collaborative leadership needed for this important role,” Connecticut Children’s president and CEO Shannon Sullivan said.
“He understands our organization from multiple perspectives–as a physician, division leader, and medical staff leader–and has demonstrated a commitment to clinical excellence, teamwork and continuous improvement.”
Over the past decade, annual patient visits grew from approximately 8,000 to 14,000, while the division’s attending physician faculty increased from seven to 13.
Isakoff is also the Hartford Whalers’ Endowed Chair for Children’s Cancer and a professor of pediatrics at the UConn School of Medicine.
“Mike brings the experience, credibility and collaborative leadership needed for this important role.”
Connecticut Children’s Shannon Sullivan
“I’m honored to take on this role and look forward to working across our organization to strengthen clinical quality and safety, improve coordination and remove barriers that can affect the delivery of care,” Isakoff said.
“Our success depends on listening to our teams, working together and keeping patients and families at the center of every decision.”
Isakoff will step down as division head of hematology and oncology as he transitions to his new position.
RELATED
EXPLORE BY CATEGORY
Stay Connected with CBIA News Digests
The latest news and information delivered directly to your inbox.



